Revolution Medicines's competitors

Revolution Medicines's competitors include NovaBay Pharmaceuticals, Chiasma, LGC Biosearch Technologies and Loxo Oncology
Add company...
Revolution Medicines
REVOLUTION Medicines is redesigning evolution's products to treat serious diseases. The company discovers and develops new drugs by deploying our innovative product engine to reconfigure substances that are inherently rich with biological function as a result of natural selection.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Chiasma
Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases.
LGC Biosearch Technologies
LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
Founding Date
Founding Date
2015
Founding Date
2000
Founding Date
2001
Founding Date
1842
Founding Date
2013
Type
Type
Private
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Redwood City, US HQ
Locations
Emeryville, US HQ
Locations
Waltham, US HQ
Ness Ziona, IL
Locations
Teddington, GB HQ
Locations
Stamford, US HQ
South San Francisco, US
Employees
Employees
514% increase
Employees
21
Employees
17
Employees
901
Employees
4757% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
52.1 m
Valuation ($)
39 m
Valuation ($)
N/A
Valuation ($)
5.1 b
Facebook likes
Facebook likes
N/A
Facebook likes
4.3 k
Facebook likes
N/A
Facebook likes
1.1 k
Facebook likes
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
2.2 k
Twitter followers
42
Twitter followers
2.4 k
Twitter followers
46

Financial

Net income
Net income
N/A
Net income
N/A
Net income
($26.8m) (FY, 2017)
Net income
(£4.3m) (FY, 2017)
Net income
($72.4m) (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 70m
Total funding raised
$ 13.6m
Total funding raised
$ 139.8m
Total funding raised
N/A
Total funding raised
$ 57m
For sources of this data, please see the company profileDownload Excel

View company profiles

NovaBay Pharmaceuticals
HQ
Emeryville, US
Employees
21

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

View company
Chiasma
HQ
Waltham, US
Employees
17

Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases.

View company
LGC Biosearch Technologies
HQ
Teddington, GB

LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.

View company
Loxo Oncology
HQ
Stamford, US
Employees
47

Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.

View company